EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Zebrafish Models of Rare Neurological Diseases like Spinocerebellar Ataxias (SCAs): Advantages and Limitations

Sreeja Sarasamma iD, Anwarul Karim iD, James P Orengo iD

Biology · 10.10.2023 · 12 (10) · 1322

DOI: 10.3390/biology12101322 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biology, online erschienen am 10.10.2023. Verfasst von Sreeja Sarasamma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Neurology and Neuroscience, Baylor College of Medicine, Houston, TX 77030, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spinocerebellar ataxia (SCA) is a heterogeneous group of rare familial neurodegenerative disorders that share the key feature of cerebellar ataxia. Clinical heterogeneity, diverse gene mutations and complex neuropathology pose significant challenges for developing effective disease-modifying therapies in SCAs. Without a deep understanding of the molecular mechanisms involved for each SCA, we cannot succeed in developing targeted therapies. Animal models are our best tool to address these issues and several have been generated to study the pathological conditions of SCAs. Among them, zebrafish (Danio rerio) models are emerging as a powerful tool for in vivo study of SCAs, as well as rapid drug screens. In this review, we will summarize recent progress in using zebrafish to study the pathology of SCAs. We will discuss recent advancements on how zebrafish models can further clarify underlying genetic, neuroanatomical, and behavioral pathogenic mechanisms of disease. We highlight their usefulness in rapid drug discovery and large screens. Finally, we will discuss the advantages and limitations of this in vivo model to develop tailored therapeutic strategies for SCA.

Schlagwörter

Stichwörter der Autor:innen

behavioral assaysdrug discoveryneurodegenerationspinocerebellar ataxiazebrafish

Autor:innen und Institutionen

  • Departments of Neurology and Neuroscience, Baylor College of Medicine, Houston, TX 77030, USA.
  • Department of Fisheries and Wildlife, Michigan State University, East Lansing, MI 48824, USA.
  • School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.

ORCID-Profile: Sreeja Sarasamma, Anwarul Karim, James P Orengo

Zitieren

APA

Sarasamma, S., Karim, A., & Orengo, J. P. (2023). Zebrafish Models of Rare Neurological Diseases like Spinocerebellar Ataxias (SCAs): Advantages and Limitations. Biology, 12(10), 1322. https://doi.org/10.3390/biology12101322

Vancouver

Sarasamma S, Karim A, Orengo JP. Zebrafish Models of Rare Neurological Diseases like Spinocerebellar Ataxias (SCAs): Advantages and Limitations. Biology. 2023;12(10):1322. doi:10.3390/biology12101322

BibTeX
@article{Sarasamma2023,
  author = {Sarasamma, Sreeja and Karim, Anwarul and Orengo, James P},
  title = {Zebrafish Models of Rare Neurological Diseases like Spinocerebellar Ataxias (SCAs): Advantages and Limitations},
  journal = {Biology},
  year = {2023},
  volume = {12},
  number = {10},
  pages = {1322},
  doi = {10.3390/biology12101322}
}
Kostenlos starten →